Virbac Reveals Latest Insights on Shares and Voting Rights

Latest Updates on Shares and Voting Rights
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS
Information regarding the total number of voting rights and shares representing the share capital is crucial for investors. This information is provided under the regulations established by the French Financial Market Authority (Autorité des Marchés Financiers), ensuring transparency in financial dealings.
The shares of Virbac are quoted on Euronext Paris, in Compartment A, with an ISIN code of FR0000031577. Investors can keep track of their investments more effectively with the information Virbac shares on this front.
Important Share and Voting Rights Breakdown
Determining the total number of shares and their respective voting rights is essential for shareholders. As of the latest report, as of the end of August 2025, the details are as follows:
Key Dates and Information
The critical date for the current share and voting rights information is August 31, 2025. The total number of shares representing the share capital stands at 8,390,660.
Understanding Voting Rights
Virbac has shared insights on the voting rights associated with these shares, providing both a gross and net total for shareholders:
- Gross total of voting rights: 12,705,441
- Net total of voting rights: 12,692,605
The net total is calculated by deducting any shares that do not carry voting rights from the overall count. Such clarity empowers shareholders to make informed decisions regarding their investments.
About Virbac
Virbac is committed to advancing the field of animal health. The company partakes in consistent reporting to inform and guide its investors. Their proactive approach establishes a solid relationship with those who invest in animal health developments.
For any inquiries, Virbac encourages direct communication. They can be reached through their corporate finance team at 33 4 92 08 71 32. Investors are also welcomed to send their questions via email to finances@virbac.com. For more information, visit their website at www.virbac.com.
Continuing Commitment to Transparency
Virbac understands the importance of transparency and accountability in the financial markets. By regularly disclosing their share and voting rights, they reinforce their dedication to maintaining shareholder trust and positioning themselves as a leader in the sector.
Frequently Asked Questions
What are the total shares for Virbac as of 2025?
As of August 31, 2025, the total number of shares representing the share capital is 8,390,660.
How many voting rights does each share have?
The gross total of voting rights is reported to be 12,705,441, whereas the net total is 12,692,605.
Where can I find more information about Virbac?
For detailed information, you can visit their website at www.virbac.com or contact their finance team directly.
What is the purpose of this declaration?
This declaration serves to inform shareholders about the current state of shares and voting rights as part of regulatory compliance.
How does Virbac ensure transparency?
Virbac ensures transparency by regularly disclosing organizational financial information to its shareholders and the public.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.